BACKGROUND: To assist physicians with difficult decisions about hospital admission for patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) presenting in the emergency department, we sought to identify clinical characteristics associated with serious adverse events. METHODS: We conducted this prospective cohort study in 6 large Canadian academic emergency departments. Patients were assessed for standardized clinical variables and then followed for serious adverse events, defined as death, intubation, admission to a monitored unit or new visit to the emergency department requiring admission. RESULTS: We enrolled 945 patients, of whom 354 (37.5%) were admitted to hospital. Of 74 (7.8%) patients with a subsequent serious adverse event, 36 (49%) had not been admitted after the initial emergency visit. Multivariable modelling identified 5 variables that were independently associated with adverse events: prior intubation, initial heart rate ≥ 110/minute, being too ill to do a walk test, hemoglobin < 100 g/L and urea ≥ 12 mmol/L. A preliminary risk scale incorporating these and 5 other clinical variables produced risk categories ranging from 2.2% for a score of 0 to 91.4% for a score of 10. Using a risk score of 2 or higher as a threshold for admission would capture all patients with a predicted risk of adverse events of 7.2% or higher, while only slightly increasing admission rates, from 37.5% to 43.2%. INTERPRETATION: In Canada, many patients with COPD suffer a serious adverse event or death after being discharged home from the emergency department. We identified high-risk characteristics and developed a preliminary risk scale that, once validated, could be used to stratify the likelihood of poor outcomes and to enable rational and safe admission decisions.
BACKGROUND: To assist physicians with difficult decisions about hospital admission for patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) presenting in the emergency department, we sought to identify clinical characteristics associated with serious adverse events. METHODS: We conducted this prospective cohort study in 6 large Canadian academic emergency departments. Patients were assessed for standardized clinical variables and then followed for serious adverse events, defined as death, intubation, admission to a monitored unit or new visit to the emergency department requiring admission. RESULTS: We enrolled 945 patients, of whom 354 (37.5%) were admitted to hospital. Of 74 (7.8%) patients with a subsequent serious adverse event, 36 (49%) had not been admitted after the initial emergency visit. Multivariable modelling identified 5 variables that were independently associated with adverse events: prior intubation, initial heart rate ≥ 110/minute, being too ill to do a walk test, hemoglobin < 100 g/L and urea ≥ 12 mmol/L. A preliminary risk scale incorporating these and 5 other clinical variables produced risk categories ranging from 2.2% for a score of 0 to 91.4% for a score of 10. Using a risk score of 2 or higher as a threshold for admission would capture all patients with a predicted risk of adverse events of 7.2% or higher, while only slightly increasing admission rates, from 37.5% to 43.2%. INTERPRETATION: In Canada, many patients with COPD suffer a serious adverse event or death after being discharged home from the emergency department. We identified high-risk characteristics and developed a preliminary risk scale that, once validated, could be used to stratify the likelihood of poor outcomes and to enable rational and safe admission decisions.
Authors: E W Steyerberg; F E Harrell; G J Borsboom; M J Eijkemans; Y Vergouwe; J D Habbema Journal: J Clin Epidemiol Date: 2001-08 Impact factor: 6.437
Authors: Ying P Tabak; Xiaowu Sun; Richard S Johannes; Linda Hyde; Andrew F Shorr; Peter K Lindenauer Journal: Med Care Date: 2013-07 Impact factor: 2.983
Authors: Frank Sciurba; Gerard J Criner; Shing M Lee; Zab Mohsenifar; David Shade; William Slivka; Robert A Wise Journal: Am J Respir Crit Care Med Date: 2003-02-20 Impact factor: 21.405
Authors: Sunghye Kim; Charles L Emerman; Rita K Cydulka; Brian H Rowe; Sunday Clark; Carlos A Camargo Journal: Chest Date: 2004-02 Impact factor: 9.410
Authors: Dina Brooks; Janet Parsons; Diem Tran; Bonnie Jeng; Barbara Gorczyca; Janet Newton; Vincent Lo; Cheryl Dear; Ellen Silaj; Therese Hawn Journal: Arch Phys Med Rehabil Date: 2004-09 Impact factor: 3.966
Authors: Shawn D Aaron; Katherine L Vandemheen; Paul Hebert; Robert Dales; Ian G Stiell; Jan Ahuja; Garth Dickinson; Robert Brison; Brian H Rowe; Jonathan Dreyer; Elizabeth Yetisir; Daniel Cass; George Wells Journal: N Engl J Med Date: 2003-06-26 Impact factor: 91.245
Authors: Ian G Stiell; Catherine M Clement; R Douglas McKnight; Robert Brison; Michael J Schull; Brian H Rowe; James R Worthington; Mary A Eisenhauer; Daniel Cass; Gary Greenberg; Iain MacPhail; Jonathan Dreyer; Jacques S Lee; Glen Bandiera; Mark Reardon; Brian Holroyd; Howard Lesiuk; George A Wells Journal: N Engl J Med Date: 2003-12-25 Impact factor: 91.245
Authors: Ian G Stiell; Jeffrey J Perry; Catherine M Clement; Robert J Brison; Brian H Rowe; Shawn D Aaron; Andrew D McRae; Bjug Borgundvaag; Lisa A Calder; Alan J Forster; Jennifer Brinkhurst; George A Wells Journal: CMAJ Date: 2018-12-03 Impact factor: 8.262
Authors: M-T García-Sanz; J-C Cánive-Gómez; N García-Couceiro; L Senín-Rial; S Alonso-Acuña; A Barreiro-García; E López-Val; L Valdés; F-J González-Barcala Journal: Ir J Med Sci Date: 2016-03-18 Impact factor: 1.568
Authors: Richard T Griffey; Ryan M Schneider; Brian R Sharp; Jeff Pothof; Marie C Vrablik; Nic Granzella; Alexandre A Todorov; Lee Adler Journal: J Patient Saf Date: 2021-12-01 Impact factor: 2.844
Authors: C Echevarria; J Steer; K Heslop-Marshall; S C Stenton; P M Hickey; R Hughes; M Wijesinghe; R N Harrison; N Steen; A J Simpson; G J Gibson; S C Bourke Journal: Thorax Date: 2016-02 Impact factor: 9.139